DGAP-Adhoc: STADA purchases British OTC manufacturer Thornton & Ross

DGAP-Adhoc: STADA purchases British OTC manufacturer Thornton & Ross

STADA Arzneimittel AG  / Key word(s): Miscellaneous

16.08.2013 12:25

Dissemination of an Ad-hoc-update according to § 15 WpHG, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bad Vilbel, August 16, 2013 - STADA Arzneimittel AG today signed and
concluded a contract for the purchase of Thornton & Ross, a British OTC
manufacturer located in Huddersfield, after STADA and the owners had
already announced exclusive contract negotiations on this issue on August
6, 2013 (see ad hoc release of August 6, 2013).

The purchase price amounts to 221,117,910 British pounds (at current
exchange rate approximately 259,223,810 Euro) in cash. This corresponds to
193 million British pounds (at current exchange rate approximately 226
million Euro) on a so-called cash and debt-free basis. Thornton & Ross has
a number of well-known prescription-free (OTC) branded products for a wide
variety of indications - among other things, cold, pain and dermatology.

Sales will presumably be consolidated in the STADA Group as of September 1,
2013. From that date, the transaction will also make a positive
contribution to net income.


Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 / 61118
Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101
603-506 / E-mail: communications@stada.de
Or visit us in the Internet at www.stada.com.


16.08.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Phone:        +49 (0)6101 603- 113
Fax:          +49 (0)6101 603- 506
E-mail:       communications@stada.de
Internet:     www.stada.de
ISIN:         DE0007251803, DE0007251845, 
WKN:          725180, 725184, 
Indices:      MDAX
Listed:       Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard);
              Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
 
Press spacebar to pause and continue. Press esc to stop.